Table 2

Distribution of visits within the cohort: rates per 100 patient-years of observation (absolute numbers in parentheses)

Outpatient Visits

Inpatient Stays



Period on ART

Initial no. of Patientsa

Patient Years

Deaths

Losses to Programb

HCTC Unscheduled

HCTC Scheduled

Tertiary

Total

Tertiary

Secondary

Tuberculosis

Total

Patients with no inpatient stay (%)


Pre-treatment

211

25

48

(12)

382

(96)

1662

(418)

115

(29)

2258

243

(61)

225

(64)

2051

(516)

2549

89

0–16 weeks

200

58

26

(15)

7

(4)

312

(181)

996

(557)

86

(50)

1427

294

(170)

478

(277)

130

(75)

902

83

17–32 weeks

181

55

4

(2)

7

(4)

174

(95)

331

(181)

59

(32)

593

187

(102)

31

(17)

218

94

33–48 weeks

175

53

6

(3)

211

(112)

352

(187)

55

(29)

654

75

(40)

186

(99)

15

(8)

276

91


49–64 weeks

132

89

2

(2)

1

(1)

173

(153)

328

(290)

46

(41)

573

38

(34)

35

(31)

73

94

65–80 weeks

89

81–96 weeks

54

97–112 weeks

15


Total

212

279

12

(34)

3

(9)

228

(637)

592

(1653)

63

(181)

920

148

(407)

175

(488)

214

(599)

537

62


Figures presented in the text may not be precisely reproducible from the data provided due to rounding. a One patient commenced ART at her first visit and therefore does not appear in the Pre-treatment period. b Losses to program consisted of eight losses to follow-up and one transfer out occurring at 0–16 weeks.

Harling et al. BMC Health Services Research 2007 7:80   doi:10.1186/1472-6963-7-80

Open Data